Related Experiment Video
Updated: Apr 26, 2026

05:22
Ex vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface
Published on: December 30, 2025
418
Common questions about late-term and postterm pregnancy
Mary Wang1, Patricia Fontaine2
1University of California, San Diego, CA, USA.
American Family Physician
|August 1, 2014
Summary
Induction at 41 weeks gestation for late-term pregnancies reduces perinatal mortality and other risks compared to expectant management. Antenatal testing may be used if expectant management is chosen.
Area of Science:
- Maternal-Fetal Medicine
- Obstetrics
- Perinatology
Background:
- Late-term pregnancy is defined as 41 weeks, 0 days to 41 weeks, 6 days' gestation, and postterm at 42 weeks' gestation.
- Accurate dating via early pregnancy ultrasonography is crucial for identifying late- or postterm pregnancies.
- Management of low-risk late-term pregnancies requires balancing maternal preference with induction versus expectant management.
Purpose of the Study:
- To evaluate the risks and benefits of induction versus expectant management for late-term pregnancies.
- To determine the optimal timing for interventions in pregnancies reaching 41 weeks' gestation.
Main Methods:
- Comparison of outcomes between induction at 41 weeks' gestation and expectant management.
- Review of evidence regarding antenatal testing protocols for late-term pregnancies.
- Consideration of maternal preferences in management decisions.
Main Results:
- Induction at 41 weeks' gestation shows a small absolute decrease in perinatal mortality compared to expectant management.
- Induction is associated with reduced fetal and maternal risks without increasing cesarean delivery rates.
- Antenatal testing, while not definitively preventing intrauterine fetal demise, is often employed due to low risks.
Conclusions:
- Induction at 41 weeks' gestation is a viable option for low-risk pregnancies, offering benefits over expectant management.
- Expectant management, if chosen, typically involves twice-weekly antenatal surveillance starting at 41 weeks.
- Induction may be deferred until 42 weeks if antenatal surveillance remains reassuring.
Related Concept Videos
Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Ovarian Cycle
5.3K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.3K
Mitral Valve Prolapse III: Nursing Management
570
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
570
Diabetes Mellitus: Type 2 and Gestational
4.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Development of the Oral Microbiota
62
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
62

